- Activities: In the Clinic: A Case-Based Discussion on Managing CSU , Ask the Experts: Insights on Influenza Diagnosis and Management, More Than Durable: Evidence and Experience With Novel Therapies for Retinal Vascular Diseases, New Horizons in the Management of Chronic Spontaneous Urticaria, Conversations in Tailoring Treatment of Complex Patients With Inflammatory Bowel Disease, Incorporating Novel Therapies in the Management of Psoriasis: The Latest Evidence and Clinical Use, The Expanding Use of Immunotherapies for Melanoma: Advances and Clinical Applications, RETINA MEETING REPORTER: Highlights From the American Society of Retina Specialists 2024 Annual Meeting, Informed Choices in NSCLC: Optimal Use of Immunotherapies Across All Stages of Disease, A Case of Psoriasis in a Patient With Depression and History of Malignancy, Psoriasis Prime Time: TYK Inhibition in Hard-to-Treat Psoriasis, Ask the Experts: HER3-Targeted Antibody-Drug Conjugates for the Treatment of Solid Tumors, Psoriasis With Scalp Involvement in a Patient With Skin of Color, Psoriasis Prime Time: The Role of TYK Inhibition in Psoriasis, Clinical Update: Targeting IgE in Food Allergy, On the Horizon: Expert Insights Into New and Emerging Novel ADCs for the Treatment of Advanced Solid Tumors, Diagnosis and Management of CSU Across Diverse Skin Colors: A Case Consult, Removing Barriers to Providing IUDs in the Primary Care Setting, Update in Food Allergy Management, Best Practices in the Management of Chronic Spontaneous Urticaria: What Do the Guidelines Tell Us?, Are Two Pathways Better Than One? Experts Discuss the Role of Ang-2/VEGF-A Inhibition in Retinal Vascular Disease, Novel Strategies to Detect and Arrest the Progression of Alzheimer s Disease Early, How Dry Am I? A Case-Based Guide to Treating Retinal Vascular Diseases, New Hope for Geographic Atrophy: An Expert Discussion of Key Practice Changes, GET REAL: A Guide to Evolving Treatment of nAMD and DME Using Real-World Data, Retina Mythbusters: Dispelling Common Myths About the Use of Dual Inhibition Therapy Versus Anti-VEGF in Retinal Vascular Diseases, Seeking Closure in Perianal Fistulizing Crohn s Disease - Research Wrap-Up 2: Clinical Use of Stem Cell Therapy for Complex Perianal Fistulas in Patients With Crohn s Disease
- Provider Ship: 1
- Provider Address: Orangeburg, NY, USA
- Activity Link: http://www.paradigmmc.com
- Number of Activities Reported Last Year: 171
- Name of Contact: Alison Kemp
- Phone Number: (845) 398-5100
- Address: 523 Route 303, Orangeburg, NY, 10962, USA
- Accreditation Status: Accreditation with Commendation
- Accredited Provider: ACCME
- Activity Format: Enduring Material, Live Course, Other/Blended Learning
Deprecated: File Theme without comments.php is deprecated since version 3.0.0 with no alternative available. Please include a comments.php template in your theme. in /nas/content/live/sleepliteracy/wp-includes/functions.php on line 6121
Leave a Reply